Preferential human eosinophil chemotactic activity of the platelet-activating factor (PAF) 1-0-hexadecyl-2-acetyl-sn-glyceryl-3-phosphocholine (AGEPC)
β Scribed by C. Elliott Sigal; Frank H. Valone; Michael J. Holtzman; Edward J. Goetzl
- Publisher
- Springer
- Year
- 1987
- Tongue
- English
- Weight
- 685 KB
- Volume
- 7
- Category
- Article
- ISSN
- 0271-9142
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
It has been shown that platelet-activating factor (PAF) specimens prepared via acetylation of 1-alkyl-sn-glycero-3-phosphocholine (lyso-PF) with acetic anhydride are heterogeneous. The contaminated compound was isolated and identified to be the structural isomer of PAF, 1-alkyl-3-acetyl-sn-glycero-2
Unsaturated platelet-activating factor (PAF) aggregates thrombocytes of healthy female volunteers and releases within 1 rain up to 30.95% of the platelet serotonin. Indomethacin does not inhibit the aggregation but reduces the release of serotonin induced by unsaturated PAF in citrated platelet-rich